Skip to main content
Log in

Nonsteroidal Anti-Inflammatory Drugs

Differential Use in Older Patients

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

The nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used medications, particularly in elderly patients, for both rheumatic and nonrheumatic conditions. Elderly patients are more prone to the adverse effects of these agents. Adverse effects are seen in almost every organ system, but the gastrointestinal tract is most frequently affected. Elderly patients are more at risk of adverse effects from a wide range of pharmacokinetic and pharmacodynamic interactions compared with younger patients. By cautious prescribing, including giving due consideration to these factors, the risks associated with NSAIDs in elderly patients can be minimised.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adams DH, Howie AJ, Michael J, McConkey B, Bacon PA, et al. Non steroidal anti-inflammatory drugs and renal failure. Lancet 1: 57–60, 1986

    Article  PubMed  CAS  Google Scholar 

  • Agrawal NM. Making sense of NSAID gastropathy and considering the therapeutic options. Scandinavian Journal of Rheumatology (Suppl. 92): 13–19, 1992

    Article  PubMed  CAS  Google Scholar 

  • Agrawal NM, Dajani EZ. Options in the treatment and prevention of NSAID-induced gastropathy. Journal of Rheumatology 17 (Suppl. 20): 7–11, 1991

    Google Scholar 

  • Agrawal NM, Saggioro A. Treatment and prevention of NSAID induced gastroduodenal mucosal damage. Journal of Rheumatology 18 (Suppl. 28): 15–18, 1990

    Google Scholar 

  • Anderson RJ, Potts DE, Gabow PA, Rumack BH, Shrier RW. Unrecognised adult salicylate intoxication. Annals of Internal Medicine 85: 745–748, 1976

    PubMed  CAS  Google Scholar 

  • Andreasen PB, Froland A, Skovsted L, Andersen SA, Hauge M. Diphenylhydantoic half life in man and its inhibition by phenylbutazone: the role of genetic factors. Acta Medica Scandinavica 193: 561–564, 1973

    Article  PubMed  CAS  Google Scholar 

  • Australian Bureau of Statistics. Australian Health Survey 1983. Cat. No. 4311.0 Canberra. Australian Bureau of Statistics, 1986

  • Benjamin SB, Ishak KG, Zimmerman HJ, Grushka A. Phenylbutazone liver injury: a clinical pathologic survey of 23 cases and review of the literature. Hepatology 1 (3): 255–263, 1981

    Article  PubMed  CAS  Google Scholar 

  • Bradley J, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of anti-inflammatory dose of ibuprofen, an analgesic dose of ibupfofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. New England Journal of Medicine 325: 87–91, 1991

    Article  PubMed  CAS  Google Scholar 

  • Brooks PM, Bell MA, Mason DI, Buchanan WW. Interactions of antirheumatic drugs. Agents and Actions 7 (Suppl. 1): 85–89, 1977

    Article  Google Scholar 

  • Brooks PM, Day RO. NSAID — differences and similarities. New England Journal of Medicine 324 (24): 1716–1725, 1991

    Article  PubMed  CAS  Google Scholar 

  • Buchanan WW. Implications of NSAID therapy in elderly patients. Journal of Rheumatology 17 (Suppl. 20): 29–32, 1990

    Google Scholar 

  • Day RO, Brooks PM. Variations in response to NSAID’s. British Journal of Clinical Pharmacology 23: 655–658, 1987

    Article  PubMed  CAS  Google Scholar 

  • Day RO, Graham GG, Williams KM. Pharmacokinetics of NSAID’s. Bailliere’s Clinical Rheumatology 2 (2): 363–393, 1988

    Article  PubMed  CAS  Google Scholar 

  • Day RO, Graham GG, Williams KM, Brooks PM. Variability in response to NSAID’s fact or fiction? Current Therapeutics 30: 31–48, March 1989

    Google Scholar 

  • Day R, Seideman P. NSAIDs, musculoskeletal disorders and gastrointestinal adverse effects. Australian Family Physician 20 (12): 1735–1737, 1991

    PubMed  CAS  Google Scholar 

  • Department of Community Services and Health. Annual Report 1988/89; Statistical Supplement 48, table 73, September, 1989

  • Dhand AK, LaBrecque DR, Metzger J. Sulindac (clinoril) hepatitis. Gastroenterology 80: 585–586, 1981

    PubMed  CAS  Google Scholar 

  • Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM. Methotrexate — nonsteroidal antiinflammatory drug interaction in children with arthritis. Journal of Rheumatology 17: 1469–1473, 1990

    PubMed  CAS  Google Scholar 

  • Edelson JT, Tosteson ANA, Sax P. Cost Effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. Journal of the American Medical Association 264: 41–47, 1990

    Article  PubMed  CAS  Google Scholar 

  • Editorial. Topical NSAIDs: a gimmick or a godsend. Lancet 2: 779–780, 1989

    Google Scholar 

  • Eng J, Sabanathan S. Drug induced oesophagitis. American Journal of Gastroenterology 86: 1127–1133, 1991

    PubMed  CAS  Google Scholar 

  • Friedman PL, Brown Jr EJ, Gunther S, Alexander RW, Barry WH, et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. New England Journal of Medicine 305: 1171–1175, 1981

    Article  PubMed  CAS  Google Scholar 

  • Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. Journal of Rheumatology 18 (Suppl. 28): 6–10, 1991

    Google Scholar 

  • Fries JF. Assessing and understanding patient risk. Scandinavian Journal of Rheumatology 92 (Suppl.): 21–24, 1992

    Article  PubMed  CAS  Google Scholar 

  • Frolich JC, Leftwich R, Raghleb M, Oates JA, Reimann I, et al. Indomethacin increases plasma lithium. British Medical Journal 1: 1115–1116, 1978

    Article  Google Scholar 

  • Gabriel SE. Is Misoprostol prophylaxis indicated for NSAID induced adverse gastrointestinal events? An epidemiologic opinion. Journal of Rheumatology 18 (7): 958–961, 1991

    PubMed  CAS  Google Scholar 

  • Geis GS, Stead H, Wallermark CB, Nicholson PA. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with RA or OA and interim report on prevention by misoprostol of diclofenac associated lesions. Journal of Rheumatology 18 (Suppl. 28): 11–14, 1991

    Google Scholar 

  • Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and ibupfofen in the elderly. Arthritis and Rheumatism 25: 1013–1015, 1982

    Article  PubMed  CAS  Google Scholar 

  • Goulder KJ, Dooley JM, Camfield PR, Fraser AD. Clinical valproate toxicity induced by acetylsalicylic acid. Neurology 37: 1392–1394, 1987

    Article  Google Scholar 

  • Graham GG, Day RO, Champion GD, Lee E, Newton K. Aspect of the clinical pharmacology of antiinflammatory drugs. Clinics in Rheumatic Diseases 10: 229–249, 1984

    PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Abernethy DR, Matlis R, Harmatz JS, Shader RI. Absorption and disposition of ibuprofen in the elderly. Arthritis and Rheumatism 27: 1066–1069, 1984

    Article  PubMed  CAS  Google Scholar 

  • Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray W. Non steroidal anti inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Annals of Internal Medicine 114 (4): 257–263, 1991

    PubMed  CAS  Google Scholar 

  • Helfgott SM, Sandberg-Cook J, Zakim D, Nestler J. Diclofenac associated hepatotoxicity. Journal of the American Medical Association 264: 2660–2662, 1990

    Article  PubMed  CAS  Google Scholar 

  • Hodinka L. Improving the risk-benefit ratio of NSAID therapy in the elderly. Scandinavian Journal of Rheumatology. (Suppl. 91): 3–8, 1991

    Article  PubMed  CAS  Google Scholar 

  • Houston MC. Non steroidal anti-inflammatory drugs and antihypertensives. American Journal of Medicine 90 (Suppl. 5A): 42S-47S, 1991

    Article  Google Scholar 

  • Hughes GRV. The problems of using NSAIDs in the elderly. Scandinavian Journal of Rheumatology (Suppl. 91): 19–25, 1991

    Article  PubMed  CAS  Google Scholar 

  • Johnson AG, Day RO. The problems and pitfalls of NSAID therapy in the elderly (Part I). Drugs & Aging 1: 130–143, 212–227, 1991

    Article  CAS  Google Scholar 

  • Kean WF, Buchanan WW. Variables affecting the absorption of NSAID’s from the gastrointestinal tract. Japanese Journal of Rheumatology 1: 159–170, 1987

    Google Scholar 

  • Kessler DA. Communicating with patients about their medications. New England Journal of Medicine 325: 1650–1652, 1991

    Article  PubMed  CAS  Google Scholar 

  • Langman MJS. Ulcer complications and NSAID’s. American Journal of Medicine 84 (Suppl. 2A): 15–19, 1988

    Article  PubMed  CAS  Google Scholar 

  • March L, Brooks P. Arthritis: the hidden disability. Medical Journal of Australia 158: 369–370, 1993

    PubMed  CAS  Google Scholar 

  • Marcus F. Pharmacokinetic interactions between digoxin and other drugs. Journal of the American College of Cardiology 5: 82A-90A, 1985

    Article  Google Scholar 

  • Maton PN. Drug therapy: omeprazole. New England Journal of Medicine 324 (14): 965–975, 1991

    Article  PubMed  CAS  Google Scholar 

  • Meffin PJ. The effects of renal dysfunction on the disposition of NSAID’s forming acyl-glucuronides. Agents and Actions 17 (Suppl.): 85–89, 1985

    PubMed  CAS  Google Scholar 

  • Mielants H, De Vos M, Goemaere S, Schelstraete K, Cuvelier C, et al. Intestinal mucosal permeability in inflammatory rheumatic diseases: I. Role of anti-inflammatory drugs. Journal of Rheumatology 18: 389–393, 1991a

    PubMed  CAS  Google Scholar 

  • Mielants H, De Vos M, Goemaere S, Schelstraete K, Cuvelier C, et al. Intestinal mucosal permeability in inflammatory rheumatic diseases: II. Role of disease. Journal of Rheumatology 18: 394–400, 1991b

    PubMed  CAS  Google Scholar 

  • Miller TA. Protective agents of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. American Journal of Physiology 245 (5): G601-G623, 1983

    Google Scholar 

  • O’Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal antiinflammatory drugs. Journal of Rheumatology 12: 13–20, 347–353, 562–567, 785–790, 1985

    PubMed  Google Scholar 

  • Pond SM, Birkett DJ, Wade DN. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulphenazole. Clinical Pharmacology and Therapeutics 22: 573–579, 1977

    PubMed  CAS  Google Scholar 

  • Reimann IW, Frolich JC. Effect of diclofenac on lithium kinetics. Clinical Pharmacology and Therapeutics 30: 348–352, 1980

    Google Scholar 

  • Richardson CJ, Blocka KLN, Ross SG, Verbeek RK. Effects of age and sex on piroxicam disposition. Clinical Pharmacology and Therapeutics 37: 13–18, 1985

    Article  PubMed  CAS  Google Scholar 

  • Ritch AES, Perera WR, Jones CH. Pharmacokinetics of azapropazone in the elderly. British Journal of Clinical Pharmacology 14: 116–119, 1982

    Article  PubMed  CAS  Google Scholar 

  • Roberts MS, Rumble RH, Wanwimolruk S, et al. Pharmacokinetics of aspirin and salicylate in elderly subjects and patients with alcoholic liver disease. European Journal of Clinical Pharmacology 25: 253–261, 1983

    Article  PubMed  CAS  Google Scholar 

  • Rochon PA, Fortin PR, Dear KBG, Minaker KL, Chalmers TC. Reporting of age data in clinical trials of arthritis. Archives of Internal Medicine 153: 243–248, 1993

    Article  PubMed  CAS  Google Scholar 

  • Rossi AC, Hsu JP, Faich GA. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. British Medical Journal 294: 147–150, 1987

    Article  PubMed  CAS  Google Scholar 

  • Roth SH. NSAID and gastropathy: a rheumatologist’s review. Journal of Rheumatology 15: 912–919, 1988a

    PubMed  CAS  Google Scholar 

  • Roth SH. Non steroidal anti-intlammatory drugs: gastropathy, deaths and medical practice. (Editorial). Annals of Internal Medicine 109 (5): 353–354, 1988b

    PubMed  CAS  Google Scholar 

  • Roth SH. Merits and liabilities o fNSAID therapies. Rheumatic Disease Clinics of North America, Vol. 15 (3): 479–498, 1989

    PubMed  CAS  Google Scholar 

  • Roth SH. Misoprostol in the prevention of NSAID-induced gastropathy. Journal of Rheumatology 17 (Suppl. 20): 20–24, 1990

    Google Scholar 

  • Roth SH, Bennett RE. Non steroidal anti-inflammatory drug gastropathy: recognition and response. Archives of Internal Medicine 147: 2093–2100, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rowland M, Riegelman S, Harris PA, Shockoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. Journal of Pharmaceutical Sciences 61: 379–385, 1992

    Article  Google Scholar 

  • Schlegel SI, Paulus HE. Non-steroidal and analgesic therapy in the elderly. Clinics in Rheumatic Diseases 12 (1): 245–273, 1986

    PubMed  CAS  Google Scholar 

  • Simon LS. Toxicities of the nonsteroidal anti-inflammatory drugs. Current Opinion in Rheumatology 4: 301–308, 1992

    Article  PubMed  CAS  Google Scholar 

  • Singh RR, Malaviya AN, Pandey JN, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet 1: 1390, 1986

    Article  PubMed  CAS  Google Scholar 

  • Stillman MT. Interaction and selection of therapeutic agents in the elderly: NSAIDs and the ageing kidney. Scandinavian Journal of Rheumatology (Suppl.) 82: 33–38, 1989

    Article  PubMed  CAS  Google Scholar 

  • Sweeney KR, Chapron DJ, Brand LJL, Gomolin IH, Feig PU, et al. Toxic interaction between acetazolamide and salicylate. Case reports and pharmacokinetic explanation. Clinical Pharmacology and Therapeutics 40: 518–524, 1986

    Article  PubMed  CAS  Google Scholar 

  • Szabo S, Piban G. Mechanisms of gastric cytoprotection. Journal of Clinical Gastroenterology 9 (Suppl. 1): 8, 1987

    Article  PubMed  Google Scholar 

  • Thyss A, Milano G, Kubar J, Namer M, Scbneider M. Clinical and pharmacokinetic evidence of a life threatening interaction between methotrexate and ketoprofen. Lancet 1: 256–258, 1986

    Article  PubMed  CAS  Google Scholar 

  • Tonkin AL, Wing LMH. Interactions of NSAID’s. Baillere’s Clinical Rheumatology 2: 455–483, 1988

    Article  CAS  Google Scholar 

  • Velo GP, Milanino R. Nongastrointestinal adverse reactions to NSAID. Journal of Rheumatology 17 (Suppl. 20): 42–45, 1990

    Google Scholar 

  • Verbeek RK. Pharmacokinetic drug interactions with NSAIDs. Clinical Pharmacokinetics 19 (1): 44–66, 1990

    Article  Google Scholar 

  • Verbeek RK, Wallace SM, Leewen GR. Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation. British Journal of Clinical Pharmacology 17: 783–784, 1984

    Article  Google Scholar 

  • Weinblatt ME. Non-steroidal anti-inflammatory drug toxicity: increased risk in the elderly. Scandinavian Journal of Rheumatology 91 (Suppl.): 9–17, 1991

    Article  PubMed  CAS  Google Scholar 

  • Weinblatt ME, Tesser JR, Gilliam JH. The liver in rheumatic diseases. Seminars in Arthritis and Rheumatism 11: 399–405, 1982

    Article  PubMed  CAS  Google Scholar 

  • Zarfin Y, Koren G, Maresky D, Perlman M, MacLeod S. Possible indomethacin-aminoglycoside interaction in preterm infants. Journal of Pediatrics 106: 511–513, 1985

    Article  PubMed  CAS  Google Scholar 

  • Zeidler H. Epidemiology of NSAID induced gastropathy. Journal of Rheumatology 18 (Suppl. 28): 2–5, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Girgis, L., Brooks, P. Nonsteroidal Anti-Inflammatory Drugs. Drugs & Aging 4, 101–112 (1994). https://doi.org/10.2165/00002512-199404020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199404020-00003

Keywords

Navigation